Impact of viral and bacterial infectious burden on long-term prognosis in patients with coronary artery disease

Circulation. 2001 Jul 3;104(1):25-31. doi: 10.1161/hc2601.091703.

Abstract

Background: The number of infectious pathogens to which an individual has been exposed (infectious burden) may correlate with coronary artery disease (CAD). In a prospective study, we evaluated the effect of 8 pathogens and the aggregate pathogen burden on the risk for future fatal cardiac events among patients with angiographically documented CAD. Methods and Results-In 1018 patients, IgG or IgA antibodies to herpes simplex virus types 1 and 2, cytomegalovirus, Epstein-Barr virus, Haemophilus influenzae, Chlamydia pneumoniae, Mycoplasma pneumoniae, and Helicobacter pylori were determined. Moreover, highly sensitive C-reactive protein was measured. Follow-up information on cardiovascular events was obtained (mean 3.1 years, maximum 4.3 years). Seropositivities to Epstein-Barr virus (P=0.001), H pylori (P=0.002), and herpes simplex virus type 2 (P=0.045) were independently associated with the future risk of cardiovascular death. An increasing number for pathogen burden was significantly predictive of the long-term prognosis (P<0.0001). Infectious burden divided into 0 to 3, 4 or 5, and 6 to 8 seropositivities was associated with an increasing mortality of 3.7%, 7.2%, and 12.6%, respectively. Patients seropositive to >5 pathogens compared with those seropositive to <4 pathogens had a 5.1 (1.4 to 18.3) higher risk of future cardiac death. This result was mainly driven by the pathogen burden of seropositivities to Herpesviridae (P<0.0001). The prognostic impact of total or viral pathogen burden was independent of the C-reactive protein level.

Conclusions: These results support the hypothesis that the number of infectious pathogens to which an individual has been exposed independently contributes to the long-term prognosis in patients with documented CAD.

MeSH terms

  • Antibodies, Bacterial / blood
  • Antibodies, Viral / blood
  • Bacterial Infections / diagnosis*
  • Bacterial Infections / epidemiology
  • Bacterial Infections / immunology
  • C-Reactive Protein / metabolism
  • Chlamydophila pneumoniae / immunology
  • Comorbidity
  • Coronary Disease / diagnosis
  • Coronary Disease / epidemiology
  • Coronary Disease / immunology
  • Coronary Disease / microbiology*
  • Cytomegalovirus / immunology
  • Female
  • Follow-Up Studies
  • Haemophilus influenzae / immunology
  • Helicobacter pylori / immunology
  • Herpesvirus 1, Human / immunology
  • Herpesvirus 2, Human / immunology
  • Herpesvirus 4, Human / immunology
  • Humans
  • Immunoglobulin G / blood
  • Male
  • Middle Aged
  • Mycoplasma pneumoniae / immunology
  • Odds Ratio
  • Prognosis
  • Risk Assessment
  • Seroepidemiologic Studies
  • Virus Diseases / diagnosis*
  • Virus Diseases / epidemiology
  • Virus Diseases / immunology

Substances

  • Antibodies, Bacterial
  • Antibodies, Viral
  • Immunoglobulin G
  • C-Reactive Protein